Lumbar Belt Benefit Compared to the Usual Care in the Treatment of Non-specific Low Back Pain
LOMBACT
2 other identifiers
interventional
168
1 country
3
Brief Summary
Lumbar belt benefit compared to the usual care in the treatment of non-specific low back pain -an interventional, prospective, multicenter, randomized, open and controlled.study
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable low-back-pain
Started Feb 2021
Longer than P75 for not_applicable low-back-pain
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 17, 2020
CompletedFirst Posted
Study publicly available on registry
January 8, 2021
CompletedStudy Start
First participant enrolled
February 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 20, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 20, 2024
CompletedSeptember 5, 2024
September 1, 2024
3.4 years
December 17, 2020
September 4, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from baseline ODI score (Oswestry Disability Index) at 12 weeks
The functional capacity is measured by ODI score.The ODI questionnaire consists in 10 questions and 6 answers modalities.The ODI score results are expressed in percentage.The higher the percentage is, the more the functional capacity is impaired.
Week: 0 and 12
Secondary Outcomes (15)
Evolution of functional capacity
Week: 0 and 4
Evolution of pain level
Week: 0, 4 and 12
Evolution of pain characteristics
Week: 0, 4 and 12
Evolution of Quality of Life
Week: 0 and 12
Assessment of doctors' opinion on improving the patient's health condition caused by low back pain and severity
Week 0, 4 and 12
- +10 more secondary outcomes
Study Arms (2)
Control group "usual care"
NO INTERVENTIONPromotion of physical activity and taking usual medicines for pain relief
Intervention group : lumbar belt
EXPERIMENTALwearing the LombaStab belt during 3 months in addition to usual care (promotion of physical activity and taking usual medicines for pain relief).
Interventions
Instruction given to the patient will be to wear the LombaStab belt from 4 to 8 hours per days, over the whole duration of the study (12 weeks). The investigator will explain to the patient how to adjust it. The LombaStab belt will be equiped with thermosensor to evaluate the belt wearing time at the end of the study.
Eligibility Criteria
You may qualify if:
- Male or female, aged from 18 to 55 years old
- Patient suffering from non-specific low back pain with current episode has progressed for 1 to 6 months
- Ability of the patient or legally authorized representative to provide a signed and dated i informed consent form before any procedure or data collection.
- Patient covered by the French Social security system.
You may not qualify if:
- Patient who has had surgical intervention on dorso-lumbar spine or lower limb the past 5 years or who has planned surgery during the study
- MODIC diagnosis (disc degeneration) known or confirmed by MRI
- Low back pain related to an accident at work
- Low back pain due to secondary origin: tumor, inflammatory, infectious cause, related to a fracture or a vertebral compression
- Patient with fibromyalgia
- Patient with lumbar radicular syndrome (radicular conflict like disc herniation, spinal stenosis...)
- Pregnant woman or trying to become pregnant during the study
- Patient with confirmed depression
- Patient with cognitive or mental disorders
- Morphology with measurements not allowing to match with the sizes of belts available
- Patient presenting chronic pathology with disabling functional consequences
- Patient with known allergy to any of the materials (see product composition in the Description section of user instruction)
- Patient with contraindicated to belt wearing: hiatus hernia, deficient respiratory functions
- Anticipated poor compliance of subject with study procedures
- Current participation in an interventional investigation drug or device treatment study with an impact on evaluation criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
CHU Grenoble Alpes
Grenoble, France
Hôpital Cochin
Paris, France
CHU de St Etienne
Saint-Etienne, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Laurent GRANGE, MD, PH
CHU de Grenoble Alpes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 17, 2020
First Posted
January 8, 2021
Study Start
February 1, 2021
Primary Completion
June 20, 2024
Study Completion
June 20, 2024
Last Updated
September 5, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share